Your Article Summary
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Vascular Health and Risk Management, 05/11/09
Reboldi G et al. - Angiotensin converting enzyme (ACE) inhibitor plus diuretic combination therapy improves blood pressure control, counterbalances renin-angiotensin system activation due to diuretic therapy and reduces the risk of electrolyte alterations, obtaining at the same time synergistic antiproteinuric effects. ACE inhibitor plus calcium channel blocker provides a significant additive effect on blood pressure reduction, may have favorable metabolic effects and synergistically reduce proteinuria and the rate of decline in glomerular filtration rate, as evidenced by the GUARD trial. Finally, the recently published ACCOMPLISH trial showed that an ACE inhibitor/calcium channel blocker combination may be particularly useful in reducing cardiovascular outcomes in high-risk patients. The present review will focus on different ACE inhibitor combinations in the treatment of patients with type 2 diabetes mellitus and hypertension, in the light of recent clinical trials, including GUARD and ACCOMPLISH.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 70%
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension. Inter-American Society of Hypertension
Hypertension, 10/29/09
Relevance Score: 69%
Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
Journal of Human Hypertension, 11/04/09
Relevance Score: 68%
Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant
Nutrition, Metabolism & Cardiovascular Diseases, 10/20/09
Relevance Score: 68%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 68%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis
Current Opinion in Nephrology and Hypertension, 12/10/09
Aldosterone and cardiovascular risk
Current Hypertension Reports, 12/10/09
Direct renin inhibition: An update
Current Hypertension Reports, 12/10/09

See Latest Articles